News about Market

Amazon Pharmacy to Deliver Foundayo Same-Day, Expanding Access to Eli Lilly's New GLP-1 Pill

Amazon Pharmacy now offers Eli Lilly’s GLP-1 pill Foundayo with real-time availability, transparent pricing from USD 1/day with insurance, USD 5/day cash, and automatic manufacturer-sponsored coupons—soon via in-office kiosks within minutes.

Market | 09/04/2026 | By News Bureau |  350

Merck Starts Tender Offer to Buy Terns Pharmaceuticals

Merck launches a tender offer to acquire Terns Pharmaceuticals, with plans to make it a wholly owned subsidiary.

Market | 08/04/2026 | By News Bureau |  215

MedGenome Study Highlights Role of RNA-Based NGS in Improving Sarcoma Diagnosis in India

India’s first prospective study finds that RNA sequencing enhances diagnostic accuracy and influences treatment decisions in complex sarcoma cases, supporting precision oncology in resource-limited settings.

Market | 08/04/2026 | By News Bureau |  171

Gilead Expands Oncology Pipeline with Tubulis Acquisition

Gilead to acquire Tubulis, adding TUB-040 ADC for ovarian cancer and a next-generation platform with Tubutecan technology, strengthening its oncology pipeline and ADC capabilities.

Market | 08/04/2026 | By News Bureau |  169

Bayer Updates Access Model for Eylea 2mg in India

Bayer revises its access model for Eylea 2mg in India to expand patient eligibility and reduce upfront costs, enabling earlier treatment for retinal diseases.

Market | 08/04/2026 | By News Bureau |  125

Biocon Launches Bosaya and Aukelso Denosumab Biosimilars in US

Biocon launches Bosaya and Aukelso denosumab biosimilars in the US following FDA approval with interchangeable status, expanding treatment options for osteoporosis and bone metastasis patients.

Market | 08/04/2026 | By News Bureau |  197

Trialt Partners with Viedoc to Streamline Clinical Trials and Enhance Data-Driven Decision-Making

The strategic collaboration between Trialt Partners and Viedoc integrates biometrics expertise with cloud-based eClinical technology to accelerate timelines and improve data quality across global studies.

Market | 07/04/2026 | By News Bureau |  141

Neurocrine to Acquire Soleno Therapeutics

Neurocrine to acquire Soleno Therapeutics, adding US FDA-approved VYKAT XR for Prader-Willi Syndrome and strengthening its rare disease and endocrinology portfolio.

Market | 07/04/2026 | By News Bureau |  189

Biocytogen and Sihuan Pharmaceutical Partner to Advance Next-Gen Antibody Therapies

The strategic collaboration between Bioctogen and Sihuan Pharmaceutical combines antibody discovery platforms and manufacturing expertise to accelerate development of innovative treatments, including weight loss therapies.

Market | 06/04/2026 | By News Bureau |  147

Glenmark Takes Charge of RYALTRIS Commercialisation in US

Glenmark will handle end-to-end commercialisation and distribution of RYALTRIS nasal spray in the US, strengthening its respiratory portfolio presence.

Market | 06/04/2026 | By News Bureau |  341